Spotify Surges 13 After Unveiling AI Music Partnership with Universal Music Group and Upbeat Guidance KilnFree Tile Startup Dekiln Partners with Johnson Tiles for Pilot Project Offering Potential Boost to UK Ceramics Sector SP 500 Marks Record Closing High on AI Enthusiasm Micron Reaches 1 Trillion Milestone Kathie Lee Gifford Lists Connecticut Estate at 100 Million Shell SHEL Receives Rating Upgrade Following ARC Resources Transaction Apples Record Surge Faces Critical Test at WWDC AI Strategy in Focus TREX Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency AFYA Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower Amid Margin Pressure SITC Q3 2025 Earnings NarrowerThanExpected Loss Drives 5098 EPS Surprise Stock Slips 189 DUO Q2 2021 Earnings Massive EPS Miss Sends Shares Lower GLDG Q1 2026 Earnings Narrowerthanexpected loss as exploration ramp continues Bar Harbor Bankshares Inc Q1 2026 Earnings Missed EPS Estimates Amid Cautious Start to the Year Alussa Energy Acquisition Corp II ALUB Holds Steady at 1002 SPAC Remains in Quiet Trading ZOOZ Strategy Ltd ZOOZ Edges Lower Testing Key Support at 028 NervGen Pharma NGEN Dips 282 to 207 Approaching Key Support Dynamix Corporation ETHM Holds Steady at 1077 as Market Awaits Catalyst Aytu BioPharma Gains 164 as Stock Tests Key Resistance at 228 Dow Jones Industrial Average Reaches Record High as Middle East Optimism Boosts Wall Street Origin Materials ORGN Q4 2025 Earnings Massive EPS Miss Amid No Revenue Reported Stock Rises 268 Erasca Inc ERAS Slides 315 as Biotech Sector Faces Pressure Key Levels to Watch IHG Q4 2025 Earnings EPS Misses Estimates Stock Edges Lower MDRR Q2 2021 Earnings Significant EPS Beat Signals Operational Resilience SWK Q1 2026 Earnings EPS Beat Drives Positive Sentiment DXR Q3 2007 Earnings Stunning Earnings Beat Driven by NonOperating Income SIM Q1 2023 Earnings EPS Misses Estimates by Wide Margin ZBIO Q1 2026 Earnings Narrower Loss Surprises Analysts as Pipeline Progress Continues NEUP Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Cuts Costs